Health Biogen Drops Alzheimer’s Drug Aduhelm, Ending a 17-year Chapter Posted on February 1, 2024 by miyuru (Reuters) -Biogen will end a post-approval study of Alzheimer’s treatment Aduhelm and return the licensing rights on the drug after failing to find a partner to mitigate costs of obtaining….